openPR Logo
Press release

Antibacterial Drugs Market to reach USD 40 Billion by 2020

06-24-2016 03:47 PM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Antibacterial Drugs Market to reach USD 40 Billion by 2020

According to a market research report published by iHealthcareAnalyst, Inc., Antibacterial Drugs Market – Global Antibacterial Drug Classes, Clinical Pipeline Analysis and Forecast 2013-2020, the global antibacterial drugs market is estimated to reach USD 40 Billion by 2020 due to high incidence of infectious diseases.

Browse the Antibacterial Drugs Market – Global Antibacterial Drug Classes, Clinical Pipeline Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/antibacterial-drugs-market/

Antibacterial drugs are derived from bacteria or molds or are synthesized de novo and can be classified in several ways - bacteriostatic or bacteriocidal, by chemical structure, according to their mode of action, or according to their spectrum of activity. Antibiotics have many mechanisms of action, including inhibiting cell wall synthesis, increasing cell membrane permeability, and interfering with protein synthesis, nucleic acid metabolism, and other metabolic processes (e.g. folic acid synthesis). The antibacterial drugs market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the drug classes (aminoglycosides; β-lactams including penicillins, carbapenems, cephalosporin; macrolides; phenicols; quinolones/fluoroquinolone; sulfonamides; and tetracyclines) and clinical pipeline analysis of phase 1,2 and 3 drugs, and forecasts growth trends (CAGR% - 2015 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends in strategic management.

The global antibacterial drugs market is segmented as:

1. Drug Class
1.1. Aminoglycosides
1.2. β-Lactams
1.2.1. Penicillin
1.2.2. Carbapenem
1.2.3. Cephalosporin
1.3. Macrolides
1.4. Phenicols
1.5. Quinolones/Fluoroquinolones
1.6. Sulfonamides
1.7. Tetracyclines
1.8. Other Antibacterials

2. Pipeline Analysis
2.1. Actoxumab/bezlotoxumab (MK-3415A)
2.2. Arikace
2.3. Cadazolid
2.4. Carbavance (meropenem/RPX7009)
2.5. Ciprofloxacin/Fluocinolone
2.6. Delafloxacin
2.7. Delamanid
2.8. Eravacycline
2.9. Omadacycline (PTK-0796)
2.10. Ozenoxacin
2.11. Plazomycin
2.12. RHB-105
2.13. Solithromycin
2.14. SPL7013
2.15. Surotomycin (MK-4261)
2.16. SYM-1219
2.17. Zempia (E-101)

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Allergan plc.
4.2. AstraZeneca plc.
4.3. Bayer
4.4. Bristol-Myers Squibb Company
4.5. Eli Lilly and
4.6. GlaxoSmithKline plc.
4.7. Johnson & Johnson
4.8. Merck & Co., Inc.
4.9. Novartis AG
4.10. Pfizer, Inc.
4.11. Sanofi

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibacterial Drugs Market to reach USD 40 Billion by 2020 here

News-ID: 345854 • Views:

More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/ Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5.5 Billion by 2025
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and Services Market to US$ 73.2 Billion by 2023
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by

All 5 Releases


More Releases for Antibacterial

Product Innovations In The Antibacterial Products Market Industry Trends Gaining …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Antibacterial Products Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for antibacterial products has witnessed a consistent growth over the past few years. A rise from $44.29 billion in 2024 to $46.38 billion in 2025 is expected, representing a compound annual growth rate (CAGR) of 4.7%. Factors
Evolving Market Trends In The Antibacterial Products Industry: Product Innovatio …
The Antibacterial Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Antibacterial Products Market Size During the Forecast Period? In recent times, there has been a steady growth in the market size of antibacterial products. A compound annual growth rate (CAGR) of
Antibacterial Washcloth Market Size 2024 to 2031.
Market Overview and Report Coverage An Antibacterial Washcloth is a type of washcloth that is designed to effectively kill bacteria and prevent the spread of germs during daily hygiene routines. These washcloths are commonly used in hospitals, nursing homes, and households to maintain cleanliness and reduce the risk of infection. The current outlook for the Antibacterial Washcloth Market is optimistic, with a projected growth rate of 10.20% during the forecasted
Antibacterial Polyurethane Systems for Filter Production
RAMPF Group, Inc. is presenting high-performance antibacterial sealing foams and casting resins based on polyurethane for filter production at AHR Expo 2023 in Atlanta, GA, from February 6 to 8 - Building C, Level 1 / C7011. Antibacterial polyurethane systems developed by RAMPF Group, Inc. are used by leading manufacturers worldwide to seal and cast filters and filter components in heating, ventilation, and air conditioning systems (HVAC). The company's product portfolio
Antibacterial Masks Market 2021 | Detailed Report
Global Antibacterial Masks Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures)
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an